A publication involving linaclotide appeared in the journal Clinical Endoscopy on August 20, 2026. The paper, titled "Efficacy of linaclotide as adjunct for bowel preparation in patients with chronic constipation: a pre-specified analysis of the APPLE trial," presents a pre-specified analysis from the APPLE trial. The publication addresses the use of linaclotide as an adjunct for bowel preparation specifically in patients with chronic constipation. This entry reflects a pre-specified analysis component of the broader APPLE trial rather than the trial's primary results. No specific findings, outcomes, or efficacy data from the analysis were included in the information available for this brief. The publication is indexed under PubMed ID 42681900. Readers interested in the specifics of the analysis, including methodology and outcomes, are encouraged to consult the full text through the journal. Linaclotide remains an approved compound, and this publication represents new peer-reviewed literature rather than a change in its regulatory status. For more background on linaclotide, including its approved uses and general profile, readers can consult the compound overview.
Linaclotide Bowel-Prep Study Published in Clinical Endoscopy
See the full linaclotide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42681900/